SEROPREVALENCE OF HUMAN PARVOVIRUS B19 AMONG VOLUNTARY BLOOD DONORS IN CHENNAI –A CROSS SECTIONAL STUDY

Dr Shoganraj S, Dr Arumugam P, Dr Deepa D

Abstract


BACKGROUND: The transfusion transmitted emerging infectious agents has become a real threat to the transfusion safety. Human parvovirus
B19 is one of the common viral infection worldwide with a potential threat of transfusion transmission.
AIM: To find out the Seroprevalence of Human parvovirus B19 among voluntary blood donors in Chennai.
MATERIALS AND METHODS: 106 blood samples from voluntary blood donors were collected in one year period from July 2015 to June 2016
and were subjected to, IgM and IgG serological tests using Novalisa ELISA kits.
RESULTS: Among 106 voluntary blood donors, 44.3% of the donors were positive for anti-B19V IgG and none were positive for anti-B19V IgM.
CONCLUSION: There is a high seroprevalence of anti-B19V IgG (44.3%) in blood donors. All donor samples in this study were seronegative for
IgM.


Keywords


Blood Donors, Human Parvovirus B19, Transfusion Transmission, Elisa Test.

Full Text:

PDF

References


Kishore, Srivastava, Choudhary et al. Standardization of B19 IgG ELISA to study the seroepidemiology of parvovirus B19 in north Indian voluntary blood donors. Asian J Transfus Sci. 2010 Jul; 4(2): 86-90

Saran RK. . In: Transfusion Medicine.Technical Manual. New Delhi. Directorate General of Health Services, Ministry of Health & Family Welfare, Government of India; 2003.p

Stramer S. L. Current perspectives in Transfusion- transmitted infectious diseases: emerging and re-emerging infections. Vox Sang. 2014 9: 30-36.

Sharad S, Kapur S. Emerging human infections : An overview on Parvovirus B19. Journal, Indian Academy of Clinical Medicine. 2005; 6(4) : 319-26.

Harvey G, David J. Mollison’s Blood Transfusion in Clinical Medicine, 12th ed.UK: John Wiley & Sons; 2014.

Mei-ying W, Harvey J, Maria Lusia A et al. Parvovirus B19 infection transmitted by

transfusion of red blood cells confirmed by molecular analysis of linked donor and recipient samples. Transfusion. 2010 Aug; jkj50: 1712-1721.

Mark K. Fung, Brenda J, Hillyer D, Westhoff M. Techinical Manual. 18th ed. United

States: AABB; 2014.

W Kumar S, Gupta RM, Sen S, et al. Seroprevalence of human parvovirus B19 in healthy blood donors. Medical Journal, Armed Forces India. 2013; 69(3):268-272. doi:10.1016/j.mjafi.2012.11.009.

Kishore J, Srivastava M, Choudhury N. Serological study on parvovirus B19 infection in multitransfused thalassemia major patients and its transmission through donor units. Asian Journal of Transfusion Science. 2011;5(2):140-143. doi:10.4103/0973-6247.83239.

Cohen BJ, Buckley MM. The prevalence of antibodies to human parvovirus B19 in England and Wales. J Med Microbiol.1988; 25:151-3.

Musa, Sunday A. U, Banwat et al. Risk of Transfusion-Transmitted Human Parvovirus B19 Infection in Anyigba and Lokoja, Kogi State – Nigeria. Iosr Journal Of Pharmacy. 2013 April Vol-3(3): 66-70.

Mahmoodian, Sharif. Detection of Human Parvovirus B19 markers in blood Samples of Donors. Iran J Virol. 2011; 5(2): 9-12.

Neal S. Young, M.D., and Kevin E. Brown, M.D. N Engl J Med 2004; 350:586-597

February 5, 2004DOI: 10.1056/NEJMra030840.

Saikawa T, Anderson S, Momoeda M et al. Neutralising linear epitopes of B19 parvovirus cluster in the VP1 unique and VP1-VP2 junction regions. J Virol 1993; 67: 3004-9.

Marano G, Vaglio S, Pupella S, et al. Human Parvovirus B19 and blood product safety: a tale of twenty years of improvements. Blood Transfusion. 2015; 13(2):184-196. doi:10.2450/2014.0174.14.

Rohrer C, Gartner B, Sauerbrei A et al. Seroprevalence of Parvovirus B19 in German Population. Epideimiol. Infect. 2008, 136, 1564-1575

Iheanacho, M.C, Akanmu S.A.& Nwogoh B. et al Seroprevalence of Parvovirus B19 Antibody in blood donors and sickle cell disease patients at lagos university teaching hospital (LUTH): A comparative study. In. AFR.J. CLN.EXPER.MICROBIOL. 15(1):14-20.

Rodis JF, Quinn DL, Gary GW Jr, et al. Management and outcomes of pregnancies complicated by human B19 parvovirus infection: a prospective study. Am J Obstet Gynecol 1990; 163:1168-71.

Gaggero, Rrivera, Calquin et al. Seroprevalence of IgG antibodies against parvovirus B19 among blood donors from Santiago, chile. Rev Med Chile. 2007; 135: 443-448.

Ayman K. Seroprevalence of Erythrovirus B19 IgG among Saudi Blood Donors in Makka, Saudi Arabia. J Fam Community Med 2009; 16(3): 111-114.

Deok, La Lee, Won Kang et al. Investigation of the prevalence of Human Parvovirus B19 DNA in Korean Plasmapheresis Donors. Korean J Lab Med. 2010; 30: 58-64.

Al-Danani D.A, Hadia Ahmed, Mokhtara, Seroprevalence of parvovirus B19 IgG among blood donors in Aden, Yemen and Alexandria, Egypt. J Chin Clin Medicine 2008 Mar; 3(3). 173-176.

Van Rijckevorsel, sonder, Maarten et al. Population –based study on the Seroprevalence of Parvovirus B19 in Amsterdam. J Med Virol 2009; 81: 1305-1309.

Deok, La Lee, Won Kang et al. Investigation of the prevalence of Human Parvovirus B19 DNA in Korean Plasmapheresis Donors. Korean J Lab Med. 2010; 30: 58-64.


Refbacks

  • There are currently no refbacks.